RS50572B - Farmaceutska kompozicija produženog oslobađanja u obliku čestica koje sadrže venlafaksin - Google Patents
Farmaceutska kompozicija produženog oslobađanja u obliku čestica koje sadrže venlafaksinInfo
- Publication number
- RS50572B RS50572B RSP-2008/0116A RSP20080116A RS50572B RS 50572 B RS50572 B RS 50572B RS P20080116 A RSP20080116 A RS P20080116A RS 50572 B RS50572 B RS 50572B
- Authority
- RS
- Serbia
- Prior art keywords
- venlafaxine
- sustained release
- release pharmaceutical
- particulate composition
- pharmaceutical particulate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Postupak za dobijanje farmaceutske kompozicije koja sadrži venlafaksin ili farmaceutski prihvatljivu so sastoji se od sledećih koraka(1) pripremanje suspenzije venlafaksina ili soli venlafaksina u rastvaraču u kome venlafaksin ili so venlafaksna poseduje rastvorljivost ne manju od 25 g/l na sobnoj temperatuti;(2) pretvaranje suspenzije iz koraka (1) u oblik čestice;(3) oblaganje čestica iz koraka (2) slojem od polimera sa produženim oslobadjanjem. Prijava sadrži još 28 patentnih zahteva.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004036641A DE102004036641A1 (de) | 2004-07-28 | 2004-07-28 | Verzögert freisetzende pharmazeutische Zusammensetzung, die Venlafaxin enthält |
PCT/EP2005/008149 WO2006010605A2 (en) | 2004-07-28 | 2005-07-27 | Sustained release pharmaceutical particulate composition comprising venlafaxine |
Publications (1)
Publication Number | Publication Date |
---|---|
RS50572B true RS50572B (sr) | 2010-05-07 |
Family
ID=35106687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RSP-2008/0116A RS50572B (sr) | 2004-07-28 | 2005-07-27 | Farmaceutska kompozicija produženog oslobađanja u obliku čestica koje sadrže venlafaksin |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1778193B1 (sr) |
AT (1) | ATE381925T1 (sr) |
CY (1) | CY1107187T1 (sr) |
DE (2) | DE102004036641A1 (sr) |
DK (1) | DK1778193T3 (sr) |
EA (1) | EA009957B1 (sr) |
ES (1) | ES2299061T3 (sr) |
HR (1) | HRP20080007T3 (sr) |
NO (1) | NO20071139L (sr) |
PL (1) | PL1778193T3 (sr) |
PT (1) | PT1778193E (sr) |
RS (1) | RS50572B (sr) |
SI (1) | SI1778193T1 (sr) |
UA (1) | UA83437C2 (sr) |
WO (1) | WO2006010605A2 (sr) |
ZA (1) | ZA200701554B (sr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10722458B2 (en) * | 2011-12-02 | 2020-07-28 | Pegasus Laboratories, Inc. | Amphipathic lipid-based sustained release compositions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL146462A (en) * | 2001-11-13 | 2015-02-26 | Lycored Bio Ltd | Prolonged-release preparations containing as an active compound and analapaxin hydrochloride |
AU2002217373A1 (en) * | 2002-01-03 | 2003-07-15 | Lek Pharmaceutical And Chemical Company D.D. | Controlled release pharmaceutical formulation containing venlafaxine |
AU2003236947A1 (en) * | 2002-06-07 | 2003-12-22 | Ranbaxy Laboratories Limited | Modified release, multiple unit drug delivery systems |
CA2507685A1 (en) * | 2002-11-28 | 2004-06-10 | Themis Laboratories Private Limited | Process for manufacturing sustained release microbeads containing venlafaxine hci |
-
2004
- 2004-07-28 DE DE102004036641A patent/DE102004036641A1/de not_active Withdrawn
-
2005
- 2005-07-27 WO PCT/EP2005/008149 patent/WO2006010605A2/en active Application Filing
- 2005-07-27 PT PT05768606T patent/PT1778193E/pt unknown
- 2005-07-27 EA EA200700159A patent/EA009957B1/ru not_active IP Right Cessation
- 2005-07-27 UA UAA200700846A patent/UA83437C2/uk unknown
- 2005-07-27 AT AT05768606T patent/ATE381925T1/de active
- 2005-07-27 DK DK05768606T patent/DK1778193T3/da active
- 2005-07-27 ES ES05768606T patent/ES2299061T3/es active Active
- 2005-07-27 RS RSP-2008/0116A patent/RS50572B/sr unknown
- 2005-07-27 DE DE602005004033T patent/DE602005004033T2/de active Active
- 2005-07-27 EP EP05768606A patent/EP1778193B1/en active Active
- 2005-07-27 SI SI200530187T patent/SI1778193T1/sl unknown
- 2005-07-27 PL PL05768606T patent/PL1778193T3/pl unknown
-
2007
- 2007-02-22 ZA ZA200701554A patent/ZA200701554B/en unknown
- 2007-02-28 NO NO20071139A patent/NO20071139L/no not_active Application Discontinuation
-
2008
- 2008-01-09 HR HR20080007T patent/HRP20080007T3/xx unknown
- 2008-02-13 CY CY20081100161T patent/CY1107187T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2006010605A2 (en) | 2006-02-02 |
WO2006010605A3 (en) | 2006-09-21 |
DE602005004033D1 (de) | 2008-02-07 |
UA83437C2 (uk) | 2008-07-10 |
PL1778193T3 (pl) | 2008-05-30 |
ATE381925T1 (de) | 2008-01-15 |
HRP20080007T3 (en) | 2008-01-31 |
EA200700159A1 (ru) | 2007-06-29 |
EA009957B1 (ru) | 2008-04-28 |
ES2299061T3 (es) | 2008-05-16 |
SI1778193T1 (sl) | 2008-06-30 |
DK1778193T3 (da) | 2008-02-04 |
PT1778193E (pt) | 2008-03-10 |
EP1778193A2 (en) | 2007-05-02 |
EP1778193B1 (en) | 2007-12-26 |
DE102004036641A1 (de) | 2006-03-23 |
NO20071139L (no) | 2007-02-28 |
DE602005004033T2 (de) | 2009-01-02 |
CY1107187T1 (el) | 2012-10-24 |
ZA200701554B (en) | 2008-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009154777A3 (en) | Process for preparing and drying solid rasagiline base | |
WO2008007151A3 (en) | Processes for preparing pharmaceutical compositions | |
WO2008091670A3 (en) | Organic semiconductor materials and precursors thereof | |
WO2008113609A3 (en) | Geopolymer composition, coating obtainable therefrom and methods | |
WO2006032026A3 (en) | Long acting injectable crystal formulations of estradiol metabolites and methods of using same | |
WO2006089674A3 (en) | Tablets with improved drug substance dispersibility | |
WO2007015003A3 (fr) | Nouvelle forme cristalline iii de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent | |
WO2008125120A3 (en) | Extract of trigonella foenum-graecum | |
WO2011077451A3 (en) | Controlled release pharmaceutical composition | |
WO2008130312A8 (en) | A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701 | |
MX2008001560A (es) | Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
UA99447C2 (ru) | Способ получения силденафила | |
WO2007147771A3 (en) | Tetralin and indane derivatives and uses thereof | |
BRPI0506283A (pt) | composição, método, e, artigo | |
WO2009007992A8 (en) | Pharmaceutical composition produced by microprecipitation | |
TW200621307A (en) | Solid dispersion composition of pranlukast with improved bioavailibility and the method of preparing the solid dispersion | |
TW200740697A (en) | Yttrium oxide composition, method of preparing the same, and method of forming yttrium oxide layer using the same | |
WO2010020799A3 (en) | Compositions for the treatment of neoplastic diseases | |
TW200833371A (en) | Process for solid formulations | |
WO2007080324A3 (fr) | Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique. | |
DK1871180T3 (da) | Fremgangsmåde til tørring af uronsyreoligosaccharider | |
PL2197967T3 (pl) | Kompozycja powłokowa zawierająca polidekstrozę, sposób jej wytwarzania i jej zastosowanie do powlekania przyjmowanych postaci stałych | |
HRP20080007T3 (en) | Sustained release pharmaceutical particulate composition comprising venlafaxine | |
WO2009013760A3 (en) | Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan | |
TW200702926A (en) | Compound dissolution inhibiting agent, positive resist composition, and resist pattern formation method |